4 hrs ago
South Wales Argus
Gwent hits two key cancer treatment targets
GWENT'S health board met its targets for the timely beginning of cancer treatments for patients during February - but Wales-wide these targets were missed.
Trending on the Topix Network
Wed Apr 16, 2014
Doctor Salaries: What They Earned in 2013
Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.
Newham's community leaders, medical experts want better cancer screening guidance
Community leaders and medical experts have played a major role in the launch of a national report that aims to tackle prostate cancer in black men.
Tahoe Daily Tribune
Prostate cancer is the silent, but deadly disease
"How do I know if I have prostate cancer?" As a urologist, I'm often asked that question.
Tue Apr 15, 2014
Medical News Today
Radical treatment for advanced prostate cancer may herald major...
For your information: MNT accounts were not affected by the recent Heartbleed bug, as we were not running a vulnerable version of OpenSSL.
WCA's robotics program celebrates one-year milestone
WCA Hospital, the region's leader in healthcare, recently celebrated the one-year anniversary of its robotics program.
Mon Apr 14, 2014
Green and black tea blend may support urinary tract health for men: Kemin Study
Daily supplements containing extracts from a blend of green and black tea varieties may improve lower urinary tract symptoms and quality of life in men in as little as six weeks, says a new study.
Adjuvant radiotherapy after prostatectomy 'risks urinary incontinence'
Men who receive adjuvant radiation therapy following radical prostatectomy face a significantly increased risk of urinary incontinence in the following years, study findings indicate.
New Fusion Technology Increases Prostate Cancer Detection Accuracy to 97 Percent
Urologists at Rush University Medical Center are the first in Chicago to offer a powerful new tool for visualizing and monitoring the prostate in men who have high prostate-specific antigen levels and in detecting prostate cancer more accurately.
Medical News Today
Men with blood type O have lower recurrence of prostate cancer
Prostate cancer is the most common cancer in men, and in 2010, it was responsible for over 28,000 deaths in the US.
Medical News Today
New survey suggests men with LUTS / BPH may not be receiving optimal treatment
Astellas Pharma Europe Ltd., the European subsidiary of Tokyo-based Astellas Pharma Inc. , announced the results of two separate studies at the annual European Association of Urology congress.
Swiss and Austrian Researchers Win Astellas European Foundation Grant ...
The Astellas European Foundation is pleased to announce the recipient of the 2014 Functional Urology and Uro-Gynaecology Grant as Dr to quantify marker levels to identify the potential relationship between Overactive Bladder Syndrome and Bladder Pain Syndrome / Interstitial Cystitis.
Lifelong premature ejaculation can be treated by pelvic floor exercises
For the first time, researchers have demonstrated that pelvic floor exercises can be effective in treating premature ejaculation in men who have had lifelong problems.
Sun Apr 13, 2014
New cancer therapy available in T&T
Discussing the merits of the new cancer therapy, from left, Rishi Maharaj, Janssen Caribbean area manager; Joan Craig, Janssen country manager South Caribbean; Dr Krishan Ramsoobhag, Urologist and Oncologist; and Dr David Muschett, oncology medical manager from Janssen.
Sat Apr 12, 2014
The Star Online
Cutting down risks: Another reason to circumcise
The removal of the foreskin is recommended by the WHO and UNAIDS as a preventative measure to limit the risk of HIV transmission, particularly in Africa.
Fri Apr 11, 2014
Customer Interaction Solutions
Immune Responses Enhanced and Sustained When PROVENGE (sipuleucel-T)...
April 11, 2014 - Dendreon Corporation today announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when PROVENGE is given after androgen deprivation therapy in patients with biochemically-recurrent prostate cancer at ... (more)
GenomeDx Biosciences Announces Data on Genomic Tests for Prostate and ...
The first poster presentation demonstrates the clinical validation of the DecipherA prostate cancer classifier for predicting treatment failure in men treated with post-surgery radiation therapy.
Avanafil Clinical Data to Be Presented at European Association of Urology
VIVUS today announced that a poster describing results of a clinical study examining onset of action of avanafil will be presented during the 29th Annual European Association of Urology Congress at StockholmsmA ssan in Stockholm, Sweden.
Thu Apr 10, 2014
Urologix Announces Strategic Restructuring, Reports Preliminary...
Urologix , Inc. , the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced a strategic restructuring of its organizational infrastructure and reported preliminary financial results for its fiscal year 2014 third quarter ended March 31, 2014.